Drug General Information
Drug ID	D0M3BB
Former ID	DIB004227
Drug Name	Synthetic hypericin
Synonyms	Hypericin; VIMRxyn; Synthetic hypericin, Nexell
Indication	Viral infections [ICD9: 054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053; ICD10:B01, B02, A60, B00, B27, G05.1, P35.2]		Phase 3	[525201]
Company	Nexell Therapeutics Inc
Structure		Download 2D MOL 3D MOL
Canonical SMILES	c12C(=O)c3c4c5c1c(c1c6c(C(=O)c7c(c56)c(c4c(cc3O)C)c(cc7<br />O)C)c(cc1O)O)c(cc2O)O
CAS Number	CAS 548-04-9
Target and Pathway
Target(s)	Protein kinase C	Target Info	Inhibitor	[527958]
References
Ref 525201	ClinicalTrials.gov (NCT02448381) Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides). U.S. National Institutes of Health.
Ref 527958	Characterization of the interaction of hypericin with protein kinase C in U-87 MG human glioma cells. Photochem Photobiol. 2006 May-Jun;82(3):720-8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.